Immunoclin Corp: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2013)
- -$13.0M
- Total Assets (FY2013)
- $21.0M
- Total Equity (FY2013)
- $20.3M
- Cash Flows from Operating Activities (FY2013)
- -$110.6K
Source: Immunoclin Corp 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
